| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 4.06e-05 | 194 | 130 | 8 | GO:0016705 | |
| GeneOntologyMolecularFunction | 2,4-dienoyl-CoA reductase (NADPH) activity | 1.26e-04 | 3 | 130 | 2 | GO:0008670 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor activity | 2.50e-04 | 4 | 130 | 2 | GO:0005006 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 2.83e-04 | 20 | 130 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation antiporter activity | 4.15e-04 | 5 | 130 | 2 | GO:0140848 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | PECR FMO4 CYP26B1 COX15 RRM1 KDM4E NDUFB3 PGK1 DECR1 TET1 KDM1B FTO CMAHP CYP4F11 | 4.74e-04 | 766 | 130 | 14 | GO:0016491 |
| GeneOntologyBiologicalProcess | cellular response to epidermal growth factor stimulus | 1.35e-05 | 49 | 129 | 5 | GO:0071364 | |
| GeneOntologyBiologicalProcess | response to epidermal growth factor | 2.19e-05 | 54 | 129 | 5 | GO:0070849 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | ERBB2 RELN ERBB4 ANGPT1 ERN1 ALS2 TNFRSF10A CHRNA3 EEF1A2 TNFSF11 EGFR | 4.89e-05 | 405 | 129 | 11 | GO:0033674 |
| GeneOntologyCellularComponent | RAVE complex | 1.16e-04 | 3 | 131 | 2 | GO:0043291 | |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 2.32e-04 | 4 | 131 | 2 | GO:0005853 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 1.19e-06 | 4 | 126 | 3 | IPR016245 | |
| Domain | GF_recep_IV | 5.91e-06 | 6 | 126 | 3 | PF14843 | |
| Domain | GF_recep_IV | 5.91e-06 | 6 | 126 | 3 | IPR032778 | |
| Domain | Recep_L_domain | 1.03e-05 | 7 | 126 | 3 | PF01030 | |
| Domain | Furin-like | 1.03e-05 | 7 | 126 | 3 | PF00757 | |
| Domain | Rcpt_L-dom | 1.03e-05 | 7 | 126 | 3 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 1.03e-05 | 7 | 126 | 3 | IPR006211 | |
| Domain | - | 1.03e-05 | 7 | 126 | 3 | 3.80.20.20 | |
| Domain | Transl_elong_EF1A_euk/arc | 4.52e-05 | 2 | 126 | 2 | IPR004539 | |
| Domain | Rav1p_C | 4.52e-05 | 2 | 126 | 2 | IPR022033 | |
| Domain | Rav1p_C | 4.52e-05 | 2 | 126 | 2 | PF12234 | |
| Domain | Noelin-1 | 1.35e-04 | 3 | 126 | 2 | PF12308 | |
| Domain | Noelin_dom | 1.35e-04 | 3 | 126 | 2 | IPR022082 | |
| Domain | Furin_repeat | 2.27e-04 | 18 | 126 | 3 | IPR006212 | |
| Domain | FU | 2.27e-04 | 18 | 126 | 3 | SM00261 | |
| Domain | RCC1 | 3.14e-04 | 20 | 126 | 3 | PF00415 | |
| Domain | RCC1_1 | 3.65e-04 | 21 | 126 | 3 | PS00625 | |
| Domain | RCC1_2 | 3.65e-04 | 21 | 126 | 3 | PS00626 | |
| Domain | RCC1_3 | 3.65e-04 | 21 | 126 | 3 | PS50012 | |
| Domain | - | 4.20e-04 | 22 | 126 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 4.20e-04 | 22 | 126 | 3 | IPR000408 | |
| Domain | - | 4.48e-04 | 53 | 126 | 4 | 1.50.40.10 | |
| Domain | Mito_carr | 4.48e-04 | 53 | 126 | 4 | PF00153 | |
| Domain | SOLCAR | 4.48e-04 | 53 | 126 | 4 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 4.48e-04 | 53 | 126 | 4 | IPR018108 | |
| Domain | Mt_carrier_dom | 4.48e-04 | 53 | 126 | 4 | IPR023395 | |
| Domain | RCC1/BLIP-II | 4.81e-04 | 23 | 126 | 3 | IPR009091 | |
| Domain | Gphrmn_rcpt_fam | 6.65e-04 | 6 | 126 | 2 | IPR002131 | |
| Domain | Transl_B-barrel | 7.79e-04 | 27 | 126 | 3 | IPR009000 | |
| Domain | Transl_elong_EFTu/EF1A_C | 1.23e-03 | 8 | 126 | 2 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 1.23e-03 | 8 | 126 | 2 | PF03143 | |
| Domain | G_TR_CS | 1.58e-03 | 9 | 126 | 2 | IPR031157 | |
| Domain | Pkinase_Tyr | 1.82e-03 | 129 | 126 | 5 | PF07714 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 1.96e-03 | 10 | 126 | 2 | IPR009001 | |
| Domain | IL-1_rcpt_fam | 2.39e-03 | 11 | 126 | 2 | IPR015621 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.45e-03 | 138 | 126 | 5 | IPR001245 | |
| Domain | Mit_uncoupling | 2.85e-03 | 12 | 126 | 2 | IPR002030 | |
| Domain | Tyr_kinase_cat_dom | 2.98e-03 | 88 | 126 | 4 | IPR020635 | |
| Domain | TyrKc | 2.98e-03 | 88 | 126 | 4 | SM00219 | |
| Domain | G_TR_1 | 3.35e-03 | 13 | 126 | 2 | PS00301 | |
| Domain | OLF | 3.35e-03 | 13 | 126 | 2 | PF02191 | |
| Domain | OLF | 3.35e-03 | 13 | 126 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 3.35e-03 | 13 | 126 | 2 | IPR003112 | |
| Domain | OLF | 3.35e-03 | 13 | 126 | 2 | SM00284 | |
| Domain | TF_fork_head_CS_2 | 3.68e-03 | 46 | 126 | 3 | IPR030456 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.90e-03 | 14 | 126 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.90e-03 | 14 | 126 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.90e-03 | 14 | 126 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.90e-03 | 14 | 126 | 2 | PF08393 | |
| Domain | MORN | 3.90e-03 | 14 | 126 | 2 | SM00698 | |
| Domain | MT | 3.90e-03 | 14 | 126 | 2 | PF12777 | |
| Domain | AAA_8 | 3.90e-03 | 14 | 126 | 2 | PF12780 | |
| Domain | TF_fork_head_CS_1 | 3.92e-03 | 47 | 126 | 3 | IPR018122 | |
| Domain | PROTEIN_KINASE_TYR | 4.22e-03 | 97 | 126 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.22e-03 | 97 | 126 | 4 | IPR008266 | |
| Domain | FH | 4.41e-03 | 49 | 126 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 4.41e-03 | 49 | 126 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 4.41e-03 | 49 | 126 | 3 | PS00658 | |
| Domain | Fork_head_dom | 4.41e-03 | 49 | 126 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 4.41e-03 | 49 | 126 | 3 | PS50039 | |
| Domain | Forkhead | 4.41e-03 | 49 | 126 | 3 | PF00250 | |
| Domain | DHC_fam | 4.48e-03 | 15 | 126 | 2 | IPR026983 | |
| Domain | MORN | 4.48e-03 | 15 | 126 | 2 | IPR003409 | |
| Domain | Dynein_heavy | 4.48e-03 | 15 | 126 | 2 | PF03028 | |
| Domain | MORN | 4.48e-03 | 15 | 126 | 2 | PF02493 | |
| Domain | Dynein_heavy_dom | 4.48e-03 | 15 | 126 | 2 | IPR004273 | |
| Domain | EFTu-like_2 | 6.44e-03 | 18 | 126 | 2 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 6.44e-03 | 18 | 126 | 2 | PF03144 | |
| Domain | G_TR_2 | 6.44e-03 | 18 | 126 | 2 | PS51722 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 1.19e-05 | 22 | 93 | 4 | M26929 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 4.41e-05 | 11 | 93 | 3 | MM15478 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 6.27e-05 | 33 | 93 | 4 | M39455 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 7.58e-05 | 13 | 93 | 3 | M27729 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 7.58e-05 | 13 | 93 | 3 | MM15320 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 9.60e-05 | 14 | 93 | 3 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 9.60e-05 | 14 | 93 | 3 | MM14531 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 1.19e-04 | 15 | 93 | 3 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 1.19e-04 | 15 | 93 | 3 | M27608 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 1.46e-04 | 16 | 93 | 3 | M562 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.46e-04 | 16 | 93 | 3 | M570 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 2.34e-04 | 46 | 93 | 4 | MM15950 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 3.24e-04 | 50 | 93 | 4 | M553 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 4.47e-04 | 23 | 93 | 3 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 4.47e-04 | 23 | 93 | 3 | M18719 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 15026342 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 12532415 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 19370475 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 24862237 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 23100016 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 25468910 | ||
| Pubmed | Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay. | 2.13e-07 | 4 | 132 | 3 | 24557338 | |
| Pubmed | Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue. | 2.13e-07 | 4 | 132 | 3 | 23991224 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 22327010 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 17177598 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 36411648 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 21203579 | ||
| Pubmed | ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site. | 2.13e-07 | 4 | 132 | 3 | 19263517 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 19447869 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 18985033 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 9556621 | ||
| Pubmed | Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours. | 2.13e-07 | 4 | 132 | 3 | 20204273 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 12807903 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 27069134 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 26021752 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 16685269 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 15345710 | ||
| Pubmed | Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. | 2.13e-07 | 4 | 132 | 3 | 12621152 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 22854050 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 9771475 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 15733067 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 8816440 | ||
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 10572067 | ||
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 15682390 | ||
| Pubmed | Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer. | 5.31e-07 | 5 | 132 | 3 | 25416285 | |
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 15254894 | ||
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 23137868 | ||
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 22554477 | ||
| Pubmed | Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway. | 5.31e-07 | 5 | 132 | 3 | 15524405 | |
| Pubmed | Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. | 5.31e-07 | 5 | 132 | 3 | 12646923 | |
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 26886748 | ||
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 7589796 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | ERBB2 EEF1A1 EEF1A1P5 EEF1A2 SLC25A3 YTHDF1 EGFR PRKCSH BAIAP2 | 6.36e-07 | 256 | 132 | 9 | 24189400 |
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 32335999 | ||
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 29190819 | ||
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 15496447 | ||
| Pubmed | LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. | 1.06e-06 | 6 | 132 | 3 | 15282549 | |
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 11278868 | ||
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 22504067 | ||
| Pubmed | Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions. | 1.85e-06 | 7 | 132 | 3 | 22493501 | |
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 17487277 | ||
| Pubmed | A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. | 1.85e-06 | 7 | 132 | 3 | 20446891 | |
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 20126551 | ||
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 22376909 | ||
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 16488402 | ||
| Pubmed | Dynamic expression of Erbb pathway members during early mammary gland morphogenesis. | 2.95e-06 | 8 | 132 | 3 | 17960183 | |
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 15306553 | ||
| Pubmed | DMXL2 NHSL2 TRPC4 GRIA4 PPIB PGK1 EEF1A1 EEF1A2 NAV1 PRKCA MTCL1 BAIAP2 CAMSAP2 GOLGA1 FOXG1 | 4.10e-06 | 963 | 132 | 15 | 28671696 | |
| Pubmed | 4.41e-06 | 9 | 132 | 3 | 34714866 | ||
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 5.76e-06 | 31 | 132 | 4 | 19136429 | |
| Pubmed | 6.29e-06 | 10 | 132 | 3 | 19298847 | ||
| Pubmed | 6.29e-06 | 10 | 132 | 3 | 8702723 | ||
| Pubmed | 6.29e-06 | 10 | 132 | 3 | 20881644 | ||
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 25315821 | ||
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 17822758 | ||
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 10821760 | ||
| Pubmed | 1.29e-05 | 134 | 132 | 6 | 24658140 | ||
| Pubmed | SART3 DMXL2 RPL35A POLE COX15 RCC1 RRM1 PPIB DMXL1 AAR2 EEF1A2 CLCN7 EGFR NECTIN2 CNDP2 PRKCSH SCFD1 BAIAP2 | 1.38e-05 | 1487 | 132 | 18 | 33957083 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25349977 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23871709 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20068085 | ||
| Pubmed | HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer. | 1.43e-05 | 2 | 132 | 2 | 23594562 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28645722 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 35524932 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 1706616 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 19946741 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 38416376 | ||
| Pubmed | Evolutionary analysis of the ErbB receptor and ligand families. | 1.43e-05 | 2 | 132 | 2 | 10824084 | |
| Pubmed | Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system. | 1.43e-05 | 2 | 132 | 2 | 20022944 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25589492 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15143334 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17307332 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18199554 | ||
| Pubmed | Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium. | 1.43e-05 | 2 | 132 | 2 | 17549377 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27502168 | ||
| Pubmed | Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases. | 1.43e-05 | 2 | 132 | 2 | 23665199 | |
| Pubmed | Epidermal growth factor receptor activity is necessary for mouse basal cell proliferation. | 1.43e-05 | 2 | 132 | 2 | 25217659 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 29572179 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 19777609 | ||
| Pubmed | Increased concentrations of growth factors and activation of the EGFR system in breast cancer. | 1.43e-05 | 2 | 132 | 2 | 23089711 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33260837 | ||
| Pubmed | The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma. | 1.43e-05 | 2 | 132 | 2 | 34487971 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18946768 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11124526 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27273260 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12354693 | ||
| Pubmed | Characterization of EGFR family gene aberrations in cholangiocarcinoma. | 1.43e-05 | 2 | 132 | 2 | 24927194 | |
| Pubmed | Fluorescence-Raman dual modal endoscopic system for multiplexed molecular diagnostics. | 1.43e-05 | 2 | 132 | 2 | 25820115 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23220854 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22699492 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20156584 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 38443188 | ||
| Pubmed | Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer. | 1.43e-05 | 2 | 132 | 2 | 17611648 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26437915 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22891338 | ||
| Interaction | NHERF1 interactions | 2.60e-06 | 183 | 128 | 9 | int:NHERF1 | |
| Interaction | NRG1 interactions | 5.11e-06 | 106 | 128 | 7 | int:NRG1 | |
| Interaction | FER1L6 interactions | 8.60e-06 | 7 | 128 | 3 | int:FER1L6 | |
| Interaction | TPT1 interactions | SART3 RPL35A ERN1 NHSL2 RFC1 PGK1 HDGFL3 EEF1A1 EEF1A2 PER2 EGFR | 1.29e-05 | 345 | 128 | 11 | int:TPT1 |
| Interaction | SLA2 interactions | 1.49e-05 | 24 | 128 | 4 | int:SLA2 | |
| Interaction | SH2B3 interactions | 1.77e-05 | 25 | 128 | 4 | int:SH2B3 | |
| Interaction | MUC4 interactions | 2.04e-05 | 9 | 128 | 3 | int:MUC4 | |
| Interaction | MAGEA1 interactions | 3.19e-05 | 95 | 128 | 6 | int:MAGEA1 | |
| Interaction | SLA interactions | 3.26e-05 | 29 | 128 | 4 | int:SLA | |
| Interaction | PTPRT interactions | 3.98e-05 | 11 | 128 | 3 | int:PTPRT | |
| Interaction | LIPC interactions | 6.21e-05 | 34 | 128 | 4 | int:LIPC | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 4.00e-07 | 4 | 85 | 3 | 1096 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.92e-03 | 14 | 85 | 2 | 762 | |
| GeneFamily | Immunoglobulin like domain containing | 2.16e-03 | 193 | 85 | 5 | 594 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 2.20e-03 | 15 | 85 | 2 | 1296 | |
| GeneFamily | Dyneins, axonemal | 2.84e-03 | 17 | 85 | 2 | 536 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-06 | 181 | 132 | 7 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 174 | 132 | 6 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 132 | 6 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-05 | 187 | 132 | 6 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 132 | 6 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-05 | 188 | 132 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-05 | 188 | 132 | 6 | 467773d1e6b4828495a62f3b92996964d1c94b97 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-05 | 188 | 132 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-05 | 188 | 132 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.14e-05 | 189 | 132 | 6 | 7f78b5bb8195f99b18082cbb612e9199b7a1538c | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 191 | 132 | 6 | 51cff0594ac7ad8c065c8ea2301f8c149bd062b4 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 191 | 132 | 6 | a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 191 | 132 | 6 | 38681a1b182d6af5cce85db5431b6eba4b20ad96 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-05 | 192 | 132 | 6 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | CV-Severe-5|CV / Virus stimulation, Condition and Cluster | 2.41e-05 | 193 | 132 | 6 | d87fcd4553b6198c3128685b73ffd1b1ae88fbb5 | |
| ToppCell | CV-Moderate-5|Moderate / Virus stimulation, Condition and Cluster | 2.55e-05 | 195 | 132 | 6 | 646d06ac3fa20acb172735c88cf45e01d212cebf | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.86e-05 | 199 | 132 | 6 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Interneuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 200 | 132 | 6 | a313b9a8bde1ea80a6eae183b76fba46b86558b4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Macroglial-Astrocyte|1m / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 200 | 132 | 6 | 4a6efb1b756995d217aacc38639c1bd40f1fd725 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-05 | 140 | 132 | 5 | 11e441c3435ad8911ab401ca7d4ae1d3e5fa6eac | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-05 | 140 | 132 | 5 | 94444b92acfad64d811ebb1545dc1dab64473795 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 7.46e-05 | 146 | 132 | 5 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-05 | 147 | 132 | 5 | f703cb0330304799d16e457215269c7732c9d5d5 | |
| ToppCell | severe_COVID-19-MAIT|World / disease group, cell group and cell class (v2) | 9.60e-05 | 154 | 132 | 5 | 65ec7f7ef05c589903c4c9fe3849478c325fdc61 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.89e-05 | 155 | 132 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 156 | 132 | 5 | 7e6805ebc7bc2f9c5965321d16922c155719970f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 156 | 132 | 5 | 741de05295b2d012ac8576378f37709a97c8fb50 | |
| ToppCell | severe_COVID-19-MAIT|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.05e-04 | 157 | 132 | 5 | 175f637e9707836bd63b5c2ccc9d4eb601c05b9e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.12e-04 | 159 | 132 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 159 | 132 | 5 | 8d958d79f5eb3ab683d1245ae7f4f22a2cefbc55 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-04 | 159 | 132 | 5 | 1baf0eaf9684668146a63192e77eec6c3c7a37f8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-04 | 161 | 132 | 5 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 162 | 132 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 132 | 5 | 361a605d8f833d9ec54b120480dce397da35f9c3 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cfh_(Cfh)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.36e-04 | 88 | 132 | 4 | 5582666aed9c1f465264f18898783872b662400d | |
| ToppCell | (05)_Ciliated-(1)_24hpi|(05)_Ciliated / shred by cell type and Timepoint | 1.36e-04 | 88 | 132 | 4 | 76959e7e3f6fae07c9881a29c28ba847be406694 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cfh_(Cfh)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.36e-04 | 88 | 132 | 4 | 5f774a85415d3cf163046f1154a82f749bf628fe | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cfh_(Cfh)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.36e-04 | 88 | 132 | 4 | f59eeaba4a3c5ef03f741ed6a31fe88f57651374 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.36e-04 | 166 | 132 | 5 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-04 | 166 | 132 | 5 | bb93db4613c067c56614ab1ca39e73ee46484387 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-04 | 166 | 132 | 5 | c1f17a028bb27b8f202bcfffa7de7373b1cdd990 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 168 | 132 | 5 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-04 | 168 | 132 | 5 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.48e-04 | 169 | 132 | 5 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.52e-04 | 170 | 132 | 5 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 170 | 132 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-04 | 170 | 132 | 5 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 170 | 132 | 5 | 8e9b5f7bfb61f8d84d0b17fb0c191da4dabad63d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 170 | 132 | 5 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.57e-04 | 171 | 132 | 5 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.57e-04 | 171 | 132 | 5 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 171 | 132 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-04 | 172 | 132 | 5 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 173 | 132 | 5 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | IIH-CD8-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.65e-04 | 173 | 132 | 5 | 4f2843371d18af766c1892529ce286f56c956fde | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 174 | 132 | 5 | 955a3de6b7efc117f34c14faf8051f41454275dd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.70e-04 | 174 | 132 | 5 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-04 | 174 | 132 | 5 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 174 | 132 | 5 | 4a6e04b4f12b87c15fa1409989cbe32c43736369 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 175 | 132 | 5 | e219b61d6bc078d44ea7d06191d3462654d857a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 175 | 132 | 5 | bd16c80418bf71127e6f1e50edf83967c9218b42 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.75e-04 | 175 | 132 | 5 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-04 | 175 | 132 | 5 | f949613ee45f5d950578c512d197716855118d18 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.75e-04 | 175 | 132 | 5 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 176 | 132 | 5 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TCM|Control / Disease, Lineage and Cell Type | 1.79e-04 | 176 | 132 | 5 | 1a7948eb86ee1da607db4d0576312b2859d94523 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.79e-04 | 176 | 132 | 5 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 176 | 132 | 5 | b942227abf9902ba13fac6c3e9efb0cacc82af94 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 176 | 132 | 5 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-04 | 177 | 132 | 5 | 85e270b4a0b0da77ffe5987a099e827c02a4adf3 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-04 | 177 | 132 | 5 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-04 | 177 | 132 | 5 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 177 | 132 | 5 | 650095a17e1a39caea74a6e89646565b9332af5d | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-04 | 177 | 132 | 5 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 177 | 132 | 5 | 81511383b010ab744ebc622c180f926d469194c1 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 177 | 132 | 5 | d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-04 | 178 | 132 | 5 | 934a2a7b35a23b56e34d4d0ef68c271513ef1fe9 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 178 | 132 | 5 | cd0c5f15e6b28ce2208346279ee9503d18d9b27d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 178 | 132 | 5 | 813d121a45e0416de1f26862851f6f0bda7ba43c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.91e-04 | 96 | 132 | 4 | 78f19fee755061b4144b1beebb60f4e8bc4dbf0d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-04 | 179 | 132 | 5 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.94e-04 | 179 | 132 | 5 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 179 | 132 | 5 | 20cac7b3035a2bb0b09f58741617550f1f623fc9 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-04 | 179 | 132 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Naive_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.99e-04 | 180 | 132 | 5 | 16516dd9c78c27fc76f58d650de9851ffa0763e7 | |
| ToppCell | IIH-CD8-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 1.99e-04 | 180 | 132 | 5 | d1a8b25115c80e5a5bd0b8244167a98250ab9778 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-04 | 180 | 132 | 5 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-04 | 181 | 132 | 5 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 181 | 132 | 5 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.04e-04 | 181 | 132 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 181 | 132 | 5 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 181 | 132 | 5 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-04 | 182 | 132 | 5 | c7e07570480295e1ad3c5fbbb16b8e4df90c690d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-04 | 182 | 132 | 5 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 182 | 132 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 182 | 132 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-04 | 182 | 132 | 5 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-04 | 182 | 132 | 5 | 6339fc979aa097627924849f436bb9e9c14f4ce3 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 182 | 132 | 5 | edfc598b7199ca1d8a399b264ab863c299b1eede | |
| Drug | pyrido[3,4-d]pyrimidine | 1.78e-07 | 3 | 129 | 3 | CID014758064 | |
| Drug | Androgen Antagonists | 4.30e-06 | 75 | 129 | 6 | ctd:D000726 | |
| Drug | but-2-enamide | 1.46e-05 | 9 | 129 | 3 | CID000031877 | |
| Drug | benzylidenemalononitrile | 1.56e-05 | 27 | 129 | 4 | CID000017608 | |
| Drug | Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 6842_UP | |
| Drug | raloxifene hydrochloride; Up 200; 0.1uM; HL60; HG-U133A | 1.70e-05 | 197 | 129 | 8 | 388_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.83e-05 | 199 | 129 | 8 | 4641_DN | |
| Drug | 6-(methylamino)pyrido(3,4-d)pyrimidine | 2.07e-05 | 10 | 129 | 3 | ctd:C107875 | |
| Drug | celecoxib | 2.63e-05 | 273 | 129 | 9 | CID000002662 | |
| Drug | BE-23372M | 2.84e-05 | 11 | 129 | 3 | CID005311105 | |
| Drug | procymidone | 2.95e-05 | 155 | 129 | 7 | ctd:C035988 | |
| Drug | Prestwick_517 | 3.16e-05 | 106 | 129 | 6 | CID000003804 | |
| Drug | N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide | 3.19e-05 | 2 | 129 | 2 | ctd:C570404 | |
| Drug | carcinolipin | 3.19e-05 | 2 | 129 | 2 | CID000159870 | |
| Drug | Lapatinib | 3.19e-05 | 2 | 129 | 2 | DB01259 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 7.97e-08 | 3 | 128 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 1.28e-05 | 11 | 128 | 3 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 1.28e-05 | 11 | 128 | 3 | C0153452 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.63e-05 | 80 | 128 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | median neuropathy (biomarker_via_orthology) | 2.80e-05 | 14 | 128 | 3 | DOID:571 (biomarker_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | ANGPT1 TRPC4 KMT2E DNAH7 PXMP2 NAV1 PRKCA PRKCSH OLFM2 FTO CMAHP PRDM6 | 3.68e-05 | 670 | 128 | 12 | EFO_0006335, EFO_0006336 |
| Disease | Osteopetrosis Autosomal Dominant Type 2 | 5.59e-05 | 3 | 128 | 2 | C3179239 | |
| Disease | Congenital Osteopetrosis | 5.59e-05 | 3 | 128 | 2 | C3645711 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 6.15e-05 | 49 | 128 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Adenocarcinoma of large intestine | 6.33e-05 | 96 | 128 | 5 | C1319315 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 7.34e-05 | 19 | 128 | 3 | DOID:2876 (is_marker_for) | |
| Disease | Infantile malignant osteopetrosis | 1.11e-04 | 4 | 128 | 2 | C1318518 | |
| Disease | transitional cell carcinoma (is_marker_for) | 1.65e-04 | 63 | 128 | 4 | DOID:2671 (is_marker_for) | |
| Disease | kallikrein-7 measurement | 1.85e-04 | 5 | 128 | 2 | EFO_0008195 | |
| Disease | Osteopetrosis | 1.85e-04 | 5 | 128 | 2 | C0029454 | |
| Disease | Cetuximab response | 1.85e-04 | 5 | 128 | 2 | cv:CN077967 | |
| Disease | Panitumumab response | 1.85e-04 | 5 | 128 | 2 | cv:CN077999 | |
| Disease | smoking behavior, body mass index | 2.04e-04 | 123 | 128 | 5 | EFO_0004318, EFO_0004340 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.14e-04 | 195 | 128 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (is_marker_for) | 2.45e-04 | 128 | 128 | 5 | DOID:4450 (is_marker_for) | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.61e-04 | 32 | 128 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 3.71e-04 | 216 | 128 | 6 | EFO_0007925, EFO_0007927 | |
| Disease | abdominal aortic artery calcification | 3.87e-04 | 7 | 128 | 2 | EFO_0004859 | |
| Disease | liver cirrhosis (is_marker_for) | 4.55e-04 | 82 | 128 | 4 | DOID:5082 (is_marker_for) | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 5.14e-04 | 8 | 128 | 2 | DOID:5520 (is_marker_for) | |
| Disease | ductal carcinoma in situ (is_marker_for) | 6.50e-04 | 39 | 128 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | autistic disorder (is_implicated_in) | 8.09e-04 | 42 | 128 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Head and Neck Carcinoma | 8.21e-04 | 10 | 128 | 2 | C3887461 | |
| Disease | Cognitive impairment | 1.00e-03 | 11 | 128 | 2 | HP_0100543 | |
| Disease | Papilloma | 1.20e-03 | 12 | 128 | 2 | C0030354 | |
| Disease | Papillomatosis | 1.20e-03 | 12 | 128 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 1.20e-03 | 12 | 128 | 2 | C0205874 | |
| Disease | urinary bladder cancer (is_marker_for) | 1.23e-03 | 107 | 128 | 4 | DOID:11054 (is_marker_for) | |
| Disease | Neoplasm of lung | 1.64e-03 | 14 | 128 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 1.64e-03 | 14 | 128 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 1.64e-03 | 14 | 128 | 2 | 211980 | |
| Disease | ovarian cancer (is_implicated_in) | 1.87e-03 | 56 | 128 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Stomach Neoplasms | 1.92e-03 | 297 | 128 | 6 | C0038356 | |
| Disease | colorectal cancer (is_implicated_in) | 1.94e-03 | 121 | 128 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Malignant neoplasm of stomach | 2.02e-03 | 300 | 128 | 6 | C0024623 | |
| Disease | urate measurement, spine bone mineral density | 2.07e-03 | 58 | 128 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Benign neoplasm of stomach | 2.43e-03 | 17 | 128 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.43e-03 | 17 | 128 | 2 | C0496905 | |
| Disease | Antibody Deficiency Syndrome | 2.43e-03 | 17 | 128 | 2 | C0003257 | |
| Disease | Carcinoma in situ of stomach | 2.43e-03 | 17 | 128 | 2 | C0154060 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.62e-03 | 63 | 128 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Adrenocortical carcinoma | 2.73e-03 | 18 | 128 | 2 | C0206686 | |
| Disease | Malignant neoplasm of endometrium | 2.73e-03 | 18 | 128 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 2.73e-03 | 18 | 128 | 2 | C0346191 | |
| Disease | carcinoma (implicated_via_orthology) | 2.74e-03 | 64 | 128 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | facial asymmetry measurement | 3.04e-03 | 19 | 128 | 2 | EFO_0009751 | |
| Disease | interstitial lung disease | 3.12e-03 | 67 | 128 | 3 | EFO_0004244 | |
| Disease | cortical thickness | CNBD1 RELN ANGPT1 LGR4 GLOD4 HDGFL3 TNFSF11 SMG7 EGFR NAV1 MTCL1 FOXC2 | 3.36e-03 | 1113 | 128 | 12 | EFO_0004840 |
| Disease | renal cell carcinoma (is_implicated_in) | 3.39e-03 | 69 | 128 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | Animal Mammary Neoplasms | 3.46e-03 | 142 | 128 | 4 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 3.46e-03 | 142 | 128 | 4 | C1257925 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.68e-03 | 71 | 128 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | bone density, lean body mass | 3.71e-03 | 21 | 128 | 2 | EFO_0003923, EFO_0004995 | |
| Disease | Stomach Carcinoma | 3.71e-03 | 21 | 128 | 2 | C0699791 | |
| Disease | glioma | 4.07e-03 | 22 | 128 | 2 | EFO_0005543 | |
| Disease | lung cancer (is_implicated_in) | 4.13e-03 | 74 | 128 | 3 | DOID:1324 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TVWELMTFGAKPYDG | 911 | P04626 | |
| YGVTIWELMTFGGKP | 906 | Q15303 | |
| FKSFGLFSKWSPYMA | 1911 | Q9HCE0 | |
| LKWNPSDYGGAEFMR | 96 | P32297 | |
| YTLGFWKTFPGKMTD | 891 | Q96Q42 | |
| MGATAGWAVTVYDKP | 1 | C9J202 | |
| YNSWEVGPKFRGVKM | 36 | Q9Y312 | |
| GGSKPFRSYWEMYLS | 71 | Q6T311 | |
| PTGWSSESYGLSKMA | 36 | Q96M93 | |
| GEGFKSLEPGWYSAM | 431 | O94923 | |
| WKEYKMGFGNPSGEY | 341 | Q15389 | |
| TGFSWRKTSKYMPRG | 236 | Q8TDJ6 | |
| FGMTYFKEASGPIWL | 526 | Q9NR16 | |
| AYWTNFAKTGDPNMG | 486 | P19835 | |
| GFSWRKTSKYMPRAS | 236 | Q9Y485 | |
| WRYMGGFAKSVSFSD | 51 | O43676 | |
| YTDKDNGGMLVWSPY | 21 | Q9P2K3 | |
| TKDGRVFAWGMGTNY | 361 | P18754 | |
| WDTGYPKRSAGEAFM | 361 | O95897 | |
| FGSYKQAEWRPDSTM | 66 | Q4ADV7 | |
| PGMAQKGYSESAWAR | 1731 | Q9Y4B5 | |
| KARFSMPGDNEGLWY | 216 | Q6ZNF0 | |
| AYMPKAAGSWVAGST | 141 | P0DN81 | |
| KGWAPTFLGYSMQGL | 121 | Q00325 | |
| EGLKAFYKGVAPLWM | 211 | Q00325 | |
| GTSGKPALEDLYWMS | 106 | Q8NHW3 | |
| ETLEYKMSWFGSKPA | 736 | Q92805 | |
| PYGMCASFFKASGQW | 481 | Q9HBX8 | |
| SKPYDGKWSKTMVGF | 61 | Q9HC38 | |
| KEEPYFGMGKMAVSW | 216 | Q9C0B1 | |
| SWIGPDHDKFSAMKY | 451 | P14314 | |
| LDGFQIPKGWSVMYS | 381 | Q9NR63 | |
| YVFGPNGGSSWMREK | 816 | O43525 | |
| TGAAIWADPGKYALM | 536 | P51798 | |
| STGPRKVGYWNDMDK | 381 | P48058 | |
| GLTFMDRAGSLYWPM | 296 | P55316 | |
| YKLPLWSMCSGADSF | 246 | O15055 | |
| GLSLMWYKSSGPGDF | 71 | Q9NZN1 | |
| FGYSGDVSPLIYWMK | 271 | Q9NZN1 | |
| MASWAKGRSYLAPGL | 1 | Q9BY49 | |
| SKPASMSHYLKAWGA | 506 | P31512 | |
| AKYMALIKEWPGYGS | 1941 | Q9HD67 | |
| NFATPRWIDYGKMAS | 291 | B2RXH2 | |
| GTMYSSWVKSPDRTG | 1061 | Q8IZD2 | |
| TGAFKPCEYLLGSWM | 526 | Q9BXB1 | |
| GKGSYWTLDPDSYNM | 141 | Q99958 | |
| PVSYFSQKGAWMDLS | 246 | Q9Y4A0 | |
| YWLFGSQMGKPVSFS | 31 | Q86WI0 | |
| WMDPSNYGGIKGKVS | 1916 | Q07864 | |
| WMGLDCGPESSKKYA | 311 | P00558 | |
| AGDLVFAKMKGYPHW | 11 | Q9Y3E1 | |
| YWKAPMFRAAGGEKT | 761 | Q06190 | |
| DAGMSWFLVKEGCYP | 1326 | P78509 | |
| FIDGGEPSKSSWMRY | 311 | Q9NQX0 | |
| SEGTAYSPKMEDWAG | 311 | P15863 | |
| SKSLAAEWGKYGMRF | 221 | Q16698 | |
| GVTVWELMTFGSKPY | 901 | P00533 | |
| MAKAPSWAGVGALAY | 1 | Q9GZV1 | |
| KKDSGFWRDFGFGMT | 421 | Q8N6G5 | |
| SPSGMWYKRAEDTAG | 926 | O75054 | |
| PWIQMAYSFVKTGGS | 761 | Q8NB78 | |
| MSALNWKPFVYGGLA | 1 | Q5SVS4 | |
| PSGSGKMIEDYWGVS | 2816 | Q8TD57 | |
| MSGEVGRITKWKYPF | 256 | O75460 | |
| GSGKWQKMEKPYAFT | 71 | Q8TCT0 | |
| AAEMGKGSFKYAWVL | 46 | Q05639 | |
| AAEMGKGSFKYAWVL | 46 | P68104 | |
| DMIFYGFLKPWLGDG | 121 | Q9HBI6 | |
| WMGKSYPSLKPLGSY | 3836 | Q8WXX0 | |
| NLMGGWKYSTFSGFL | 206 | Q8IUK8 | |
| FGLNMKLGYGKFSWP | 6 | Q9P2S6 | |
| YTPMKGGISNVWFDR | 66 | Q5VWZ2 | |
| AAEMGKGSFKYAWVL | 46 | Q5VTE0 | |
| GKGTYWSLDPASQDM | 176 | Q9NU39 | |
| AGLVYNSFPKMGESW | 286 | Q7KZN9 | |
| MEGSVPIRDSWSKYF | 251 | Q6ZMB0 | |
| VFYNGAWGTVGKSSM | 841 | Q86VB7 | |
| RAVAAATYKTMGPAW | 41 | Q15020 | |
| SMSYVDGFIGTWPKE | 416 | Q08AD1 | |
| RYWNGGGKEESSSKM | 841 | Q9P232 | |
| VMKSWSTGYPKRSAG | 381 | Q96PB7 | |
| PKSSAYAMNYWRKLG | 236 | Q12889 | |
| YDSGSLKMEPGTSKW | 486 | Q8NEY1 | |
| MWLGEKLGFYTDFGP | 481 | Q9H720 | |
| MSGRLWSKAIFAGYK | 1 | P18077 | |
| TETGKMFTWGRADYG | 281 | Q9UGK8 | |
| RKGMPGDWKNYFTVA | 266 | Q6IMI6 | |
| GKAMPWFQFYLTGAT | 211 | Q8IWB6 | |
| LKSPAGKFWQTMGFS | 91 | Q7Z6J9 | |
| DAFGAAAMLAKGSWP | 271 | A6NKL6 | |
| FGVSELMKMPASGWY | 261 | P17252 | |
| SWKGDAFTYMTPSAT | 391 | Q5HYW2 | |
| FPSGYTLKKMWITAF | 326 | Q96DL1 | |
| GYMTQFPTFPSWLGK | 951 | P35251 | |
| SAMPWGDPSYKSANF | 186 | Q96A37 | |
| TFLYMDPEGDWFLKG | 156 | Q8WUX1 | |
| FSGESGPMIYWMKGE | 271 | Q9NP60 | |
| WKTDKPAMGGFGIDY | 1046 | Q92540 | |
| ENFKLKHYGPGWVSM | 126 | P23284 | |
| EEPTTWTGYFGKVLM | 286 | Q9Y4P8 | |
| FMRKGTAGDWKNYFT | 256 | O43704 | |
| MGSPLGHFTWDKYLK | 21 | Q96GD3 | |
| WSMYFNGCKFGRSPS | 1581 | Q8NFU7 | |
| GVWSMPSKYSEEGVY | 201 | Q9NUJ1 | |
| GESEKTKMRGWFPFS | 416 | Q9UQB8 | |
| PMTFSGGKFTEEWKA | 211 | Q9Y471 | |
| WFYIDFGGVKPMGSE | 606 | Q9UJS0 | |
| LPSYDSMLSKWSTFG | 251 | Q8NA66 | |
| VYMGHGGKPWVSDFS | 376 | Q96KP4 | |
| GGDVKYTTWMFETQP | 436 | A4UGR9 | |
| MSGLNWKPFVYGGLA | 36 | O95258 | |
| GVTMWEALSYGQKPY | 526 | P43403 | |
| DASAFAAKMRGGFWP | 136 | Q9NR77 | |
| KFSMGSRKGSLYNWT | 331 | Q96MK2 | |
| TSMHFYGWKQGLKTG | 721 | P23921 | |
| KGMNFTWKTYNPAFS | 296 | Q9P2C4 | |
| ARFSGTWYAMAKKDP | 36 | P02753 | |
| MTTKDYPSLWGFGTT | 1 | Q07617 | |
| VPGYTKKVGSEWMYS | 966 | Q8IZH2 | |
| PSGAYFAWKATAMGK | 151 | P25787 | |
| WKAFTKMASAPASYG | 496 | Q8WVM8 | |
| YNEKTPGYMGASWVD | 361 | Q86WI1 | |
| TAGPGDALYAMLMKW | 401 | O00220 | |
| MKGGSTKYWSGNSEF | 256 | O14788 | |
| FTAWYSDMETPLKAG | 476 | O95361 | |
| GTFWGYPKMLEAANL | 6 | P15621 | |
| FSKWDAGCKGYSMIV | 456 | Q08AF3 | |
| GTIGAVAAWLMSYKP | 11 | H3BTG2 | |
| TFPKMLYCNWTGGYK | 171 | Q9BRN9 | |
| KLWMSYFEEGGTLPT | 641 | Q9UBN4 | |
| EMKSPVDYGTSAGVW | 451 | Q9BYJ9 | |
| TLGYGDMYPKTWSGM | 436 | Q03721 | |
| FYMLKGSWEAGNPSC | 491 | Q86W24 | |
| EFATFPKGSVRGMTW | 141 | Q92692 |